HomeCOYA • NASDAQ
add
Coya Therapeutics Inc
Previous close
$5.63
Day range
$5.45 - $5.83
Year range
$4.65 - $10.24
Market cap
91.15M USD
Avg Volume
44.11K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 257.88K | 103.32% |
Operating expense | 2.72M | 11.20% |
Net income | -7.31M | -44.63% |
Net profit margin | -2.83K | 28.86% |
Earnings per share | -0.44 | — |
EBITDA | -7.67M | -40.71% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 35.53M | -1.27% |
Total assets | 38.40M | 2.71% |
Total liabilities | 5.04M | 0.70% |
Total equity | 33.37M | — |
Shares outstanding | 16.72M | — |
Price to book | 2.82 | — |
Return on assets | -46.38% | — |
Return on capital | -52.62% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -7.31M | -44.63% |
Cash from operations | -2.83M | -231.80% |
Cash from investing | — | — |
Cash from financing | 19.14K | -98.46% |
Net change in cash | -2.81M | -183.54% |
Free cash flow | -68.58K | -101.96% |
About
Founded
2020
Headquarters
Website
Employees
8
